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Abstract
Introduction: Substantial effort has been devoted for devising effective and safe interventions to reduce
preventable hospital admissions in chronic disease patients. In rheumatoid arthritis (RA), identifying risk factors for
admission has important health policy implications, but knowledge of which factors cause or prevent hospital
admissions is currently lacking. We hypothesised that disease activity/severity and physical activity are major
predictors for the need of hospitalisation in patients with RA.
Methods: A total of 244 RA patients were assessed for: physical activity (International Physical Activity
Questionnaire), RA activity (C-reactive protein: CRP; disease activity score: DAS28) and disability (Health Assessment
Questionnaire: HAQ). The number of hospital admissions and length of hospitalisation within a year from baseline
assessment were collected prospectively.
Results: Disease activity and disability as well as levels of overall and vigorous physical activity levels correlated
significantly with both the number of admissions and length of hospitalisation (P < 0.05); regression analyses
revealed that only disease activity (DAS28) and physical activity were significant independent predictors of
numbers of hospital admissions (DAS28: (exp(B) = 1.795, P = 0.002 and physical activity: (exp(B) = 0.999, P = 0.046))
and length of hospitalisation (DAS28: (exp(B) = 1.795, P = 0.002 and physical activity: (exp(B) = 0.999, P = 0.046).
Sub-analysis of the data demonstrated that only 19% (n = 49) of patients engaged in recommended levels of
physical activity.
Conclusions: This study provides evidence that physical activity along with disease activity are important
predictors of the number of hospital admissions and length of hospitalisation in RA. The combination of lifestyle
changes, particularly increased physical activity along with effective pharmacological therapy may improve multiple
health outcomes as well as cost of care for RA patients.
Introduction
Rheumatoid arthritis (RA), the most common chronic
inflammatory arthritis, typically leads to physical disabil-
ity and worse quality of life. Its associated health effects
result in significant treatment costs compared to patients
with other chronic diseases or the general population
[1,2], including hospitalisation costs due to the increased
number of admissions, which create a large economic
burden [1]. The introduction of biological treatments for
RA has increased drug-related costs [3,4], but reduced
the need for hospital admissions [5]. However, there may
be several other contributors to hospital admissions in
patients with RA.
Investigating the ways that non-pharmacological inter-
ventions may improve RA outcomes, most importantly
increased physical activity, has been an interesting
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challenge for rheumatology health professionals. This is
because it is difficult to overcome the pain and physical
disability barriers that accompany this disease and con-
vince patients that exercise and/or increased physical
activity will improve disease outcomes [6]. Because of
this, it is not surprising that there is a high prevalence of
physical inactivity in regular clinical RA patients in 21
countries [7]. Nevertheless, pooled evidence reveals that
participation in exercise has beneficial effects on RA dis-
ease activity and severity as it inhibits disease progression
without inducing flares [8]. Moreover, increased physical
activity may improve the cost-effectiveness of treatment
particularly in patients with increased cardiovascular risk
[9], as is the case for RA patients [10].
The number of hospital admissions and length of hos-
pitalisation represent very important parameters that
may affect cost of treatment and quality of life. Therefore,
substantial effort has being devoted to devise effective
and safe interventions to reduce preventable hospital
admissions in patients with many diseases [9]. In RA,
identifying risk factors for admission has important
health policy implications, but knowledge of which fac-
tors associate with hospital admissions and/or length of
hospitalisation is currently lacking. Such knowledge is
crucial given that, identifying predictors of hospital
admissions may help focus provision of care on the indi-
viduals at risk and allow targeted interventions. The main
aim of this study was to investigate whether RA disease
activity and disability and/or involvement in physical
activity are significant predictors of the number of hospi-




Two hundred and forty-four consecutive patients with RA,
meeting the revised RA American College of Rheumatol-
ogy classification criteria [11], were recruited from the
clinics of the Dudley Group of Hospitals NHS Foundation
Trust, UK. Prior to participation, verbal and written infor-
mation about the study was given to the participants.
Upon deciding to participate, a written informed consent
was signed and a follow-up visit was arranged at the Rheu-
matology Clinical Research Unit. The study was approved
by the Black Country research ethics committee and
research and development directorate.
Procedures
Patients visited our laboratory following a 12 h overnight
fast. On that day, we have initially collected our patients’
demographic data followed by evaluation of anthropo-
metric characteristics. Height was assessed via a Seca
Stadiometer 208, whereas weight, body mass index, body
fat and fat-free mass were measured via bioelectrical
impedance (Tanita BC 418 MA, Tanita Corporation,
Tokyo, Japan). Using standardised laboratory procedures,
contemporary serological inflammatory load and clinical
disease activity were assessed by the erythrocyte sedimen-
tation rate (ESR), C-reactive protein (CRP) and the Dis-
ease Activity Score-28 (DAS28). Functional disability was
self-reported via the Health Assessment Questionnaire
(HAQ). Disease duration was recorded from reviews of
the participants’ hospital notes.
The long version of the international physical activity
questionnaire (IPAQ) was used to assess levels of the
patients’ physical activity. The IPAQ is suitable for patient
populations [12] as it is divided in specific parts, each
addressing the physical activities that patients with chronic
disease are most likely to perform: job-related, transporta-
tion, housework, leisure time, and time spent sitting.
Further, the IPAQ utilises as its unit “MET-min/week”,
where MET is the metabolic and/or energy cost of physi-
cal activities.
Data for numbers and reasons for hospital admissions as
well as the length of hospitalisation (that is, total days that
a patient stayed as an inpatient at the hospital as a result
of the admission) per patient were provided by the hospi-
tal’s information department. Reasons for hospital admis-
sion were classified in major categories, including:
treatment for RA flare (including treatment for severe
pain and joint aspiration and injection), single or multiple
diagnostic tests requiring admission, emergency admis-
sions for other reasons (for example, infections, cardiovas-
cular emergencies), emergency or elective operations (for
example, for fractures or joint replacements). Routine vis-
its were not included in the present analyses in order to
focus the investigation on care required in addition to rou-
tine outpatient monitoring appointments or visits for rou-
tine day-case therapy.
Statistical analyses
Kolmogorov-Smirnov normality tests were utilised to
investigate the normal distribution of data. Paired-samples
t-test or Mann-Whitney U tests were utilised for compari-
sons between groups (depending on the normality of the
distributions). For correlation coefficient and regression
analyses, the number of hospital admissions was dichoto-
mised in “zero to one” and “above one” whereas the length
of hospitalisation was dichotomised into “zero” and “one
and above"; this approach was adopted due to the severe
skew of both these variables. Following dichotomisation,
Spearman’s rank correlation was used to evaluate the rela-
tionships of both these variables with HAQ, DAS28, ESR,
CRP, disease duration, age, overall and vigorous physical
activity. The number of hospital admissions and length of
hospitalisation (again both as dichotomous variables),
were used as dependent variables in binary logistic regres-
sion analyses to assess the effect of various different
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predictor variables (HAQ, DAS28, ESR, CRP, disease dura-
tion, age, overall and vigorous physical activity). Further
bivariate analyses and regressions were run to examine
predictors of the demographic or RA-related variables
associated with hospital admissions and length of hospita-
lisation following Baron and Kenny’s criteria of mediation
effects [13]. All statistical analyses were conducted using
SPSS (version 16, Chicago, IL, USA).
Results
The general characteristics of the patients appear in
Table 1. The level of physical activity (PA) of this
patient group was 1,550 (989.5 to 2,175.0) MET-min-
utes/week. From our total sample size (n = 244), 39%
(n = 94) were admitted to the hospital within one year.
The number and frequencies for hospital admissions
appear in Table 2. Regarding the length of hospitalisa-
tion, 32 patients (out of the 94 patients admitted) stayed
as inpatients at the hospital after they were admitted.
The length of hospitalisation for these 32 patients was:
a) between one to five days for eight patients (25% of
the 32 patients), b) between six and 10 days for six
patients (19% of the 32 patients), and c) above 10 days
for 18 patients (56% of the 32 patients), whereas the rea-
sons for hospitalisation were: infusions/injections (n =
20), pain (n = 2), joint replacement (n = 4), fractures




Functional disability (HAQ), disease activity (DAS28),
inflammatory markers (CRP and ESR) significantly corre-
lated with the number of admissions (HAQ: rho = 0.214,
P = 0.001; DAS28: rho = 0.183, P = 0.008; CRP: rho =
0.169, P = 0.008; ESR: rho = 0.161, P = 0.012) whereas
this was not the case for disease duration or patient’s age
(P < 0.05). Frequency/amount (in MET-minutes/week) of
Table 1 Demographic, anthropometric and clinical characteristics of the study population number
General demographics
Males (n = 70) Females (n = 174) Total
Physical activity (MET-minutes/week) 1,674.5 (982.5 to 2,479.2) 1,470.0 (993.0 to 2,082.5) 1,550 (989.5 to 2,175.0)
Age (years) 62.1 (55.8 to 68.7) 62.3 (52.8 to 70.2) 62.1 (53.8 to 69.4)
Smoking status
current smokers n (%) 14 (20.9%) 31 (18.1%) 45 (18.9%)
Anthropometric
Height (cm) 172.9 ± 7.1 160.7 ± 6.9* 164.2 ± 8.8
Weight (kg) 81.7 (73.1 to 93.0) 70.8 (61.6 to 81.3)** 73.8 (64.9 to 84.0)
Body Mass Index (kg/m2) 27.1 (25.0 to 30.3) 26.7 (24.1 to 31.7) 27.0 (24.4 to 30.8)
Fat-free mass (kg) 58.6 (53.1 to 65.4) 43.4 (39.1 to 46.9)** 45.9 (41.4 to 53.1)
Fat mass (%) 28.6 (22.2 to 31.8 38.8 (34.6 to 43.1)** 36.2 (29.7 to 40.8)
RA characteristics
General characteristics
Rheumatoid factor positive n (%) 45 (72.6%) 118 (77.1%) 163 (75.8%)
Disease duration (years) 9.0 (3.5 to 18.0) 11.0 (4.0 to 20.0) 11.0 (4.0 to 19.0)
Disease activity
C-Reactive protein (mg/L) 11.5 (6.0 to 22.2) 8.0 (5.0 to 20.0) 9.0 (5.0 to 21.0)
ESR (mm/1 hr) 23.0 (5.0 to 39.0) 22.0 (12.2 to 39.0) 23.0 (10.0 to 39.0)
Disease activity score 28 4.3 ± 1.4 4.2 ± 1.5 4.2 ± 1.4
Disability
Health assessment Questionnaire 1.2 (0.5 to 2.1) 1.5 (0.5 to 2.1) 1.5 (0.5 to 2.1)
Medication
DMARDs n (%) 65 (92.9%) 144 (83.2%)* 209 (86%)
Methotrexate n (%) 41 (58.6%) 95 (54.9%) 136 (56%)
antiTNFa n (%) 6 (8.6%) 24 (13.9%) 30 (12.3%)
leflunomide n (%) 1 (1.4%) 10 (5.8%) 11 (4.5%)
prednisolone n (%) 30 (42.9%) 51 (29.5%) 81 (33.3%)
NSAID n (%) 16 (22.9%) 30 (17.3%) 46 (18.9%)
Cholesterol-lowering n (%) 16 (22.9%) 28 (16.2%) 44 (18.1%)
Results expressed as number (percentages), median (interquartile range) or mean ± SD as appropriate.
ESR, erythrocyte sedimentation rate, DMARDs, disease modifying anti rheumatic drugs, NSAID, non-steroid anti-inflammatory drugs
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overall physical activity and ‘vigorous’ physical activity
demonstrated significant negative correlations with the
number of admissions (rho = -0.262, P < 0.001 and rho =
-0.270, P < 0.001, respectively).
Length of hospitalisation
HAQ, DAS28 and inflammatory markers (CRP and ESR)
also revealed significant correlations (HAQ: rho = 0.280,
P < 0.001; DAS28: rho = 0.225, P = 0.001; CRP: rho =
0.147, P = 0.022; ESR: rho = 0.249, P < 0.001). Physical
activity and vigorous physical activity were again inversely
correlated with length of hospitalisation (rho = -0.231, P <
0.001 and rho = -0.295, P < 0.001, respectively). No other
parameters revealed significant correlations with length of
hospitalisation.
Regression analyses
We have performed two different binary logistic regres-
sions for the numbers of hospital admission as well as
the length of hospitalisation, respectively. Based on the
results from the correlations, in both models we used as
independent variables HAQ, DAS28, CRP and ESR in
an initial forward entry step, followed by overall physical
activity and ‘vigorous’ physical activity on a final step. In
the first step, only DAS28 was a significant predictor
(exp(B) = 1.437, P = 0.005) whereas in the final step,
both overall physical activity (exp(B) = 0.999, P = 0.005)
and DAS28 (exp(B) = 1.397, P = 0.011) were both signif-
icant predictors of the number of hospital admissions
(Figure 1). Similarly, DAS28 significantly predicted
length of hospitalisation (exp(B) = 1.815, P = 0.001)
whereas during the final step both DAS28 and overall
physical activity were significant predictors ((exp(B) =
1.795, P = 0.002 and (exp(B) = 0.999, P = 0.046).
In a sub-analysis of our data we found that only 19%
(n = 49) of participants were engaged in recommended
levels of physical activity (≥ 5 times/week for ≥ 30 min-
utes). This group of participants had a significantly
lower number of admissions compared to the remaining
patients (physically active: 0.0 (0.0 to 0.0) vs. inactive:
0.0 (0.0 to 2.0), P < 0.001). In addition, patients achiev-
ing recommended levels of physical activity had signifi-
cantly less swollen joints (3.0 (1.0 to 6.0) vs. 4.0 (2.0 to
8.0), P = 0.02] as well as significantly better physical
function (HAQ: 1.0 (0.0 to 2.0) vs. 2.0 (0.0 to 2.0), P =
0.001). However, this group was significantly younger
(physically active vs. inactive: age 56.8 ± 13.1 vs. 62.9 ±
11.5 years, P = 0.001) but did not have significantly dif-
ferent disease duration compared to the physically inac-
tive group (P > 0.05). In an additional logistic
regression, it was found that both younger age and
lower CRP were significant predictors of whether parti-
cipants met the recommendations for physical activity
(exp(B) = 0.55, P = 0.02), regardless of their DAS28 and
HAQ scores.
Discussion
This study investigated for the first time the impact of
physical activity levels on hospital admissions and length
of hospitalisation over one year in patients with RA.
Our results revealed that disease activity and physical
activity are both significant predictors of these two
variables.
Studies with RA patients reveal that, due to the high
prevalence of co-morbidities [5], patients feel uncertain
about the outcomes of their disease and hence, admission
to the hospital may have deleterious effects, particularly
in patients with early disease [14]. Hospitalisation may
lead to negative self-esteem and loss of privacy [14] and
Table 2 Total number of hospital admissions across one
year
Number of Hospital Admissions Number (%) of RA patients
0 150 (61%)
1 to 5 77 (31%)
6 to 10 5 (2%)
11 to 20 4 (2%)





Admission to Hospital 
+
Length of hospitalisation 
Figure 1 Variables associated with RA-related hospital admission over the course of a year.
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may have a significant, lasting adverse impact on the
quality of life of the patient. It also associates with very
high costs to the health system. Hence, it is important to
identify strategies that may improve overall management
and reduce hospitalisation in this patient group.
To this end, improved pharmacological therapy for RA,
particularly after the introduction of biological medica-
tion with anti-TNFa agents, has significantly improved
disease management and appears to reduce hospital
admissions and lengths of stay [15], but it also increased
direct drug costs [2,4,16]. A very important factor that
may considerably affect RA management is lifestyle
change with increased involvement in exercise and/or
physical activity. The results from the present study may
also suggest beneficial effects of physical activity, both to
the individual patients and the healthcare system, by a
reduction of the number and length of hospitalisation.
However, the cross sectional design adopted herein can-
not prove definite causality and it is likely that the num-
ber of hospital admissions as well as the length of
hospitalisation is mediated by many different factors,
which have to be investigated in relevant trials. Our sug-
gestion for a potential association of increased physical
activity with reduced admission rates lies in robust
research evidence which have consistently shown that
regular exercise and physical activity significantly
improve RA patient outcomes (by promoting beneficial
body composition changes and reducing fatigue), inhibit
progression of the disease (by reducing inflammation and
increasing muscle mass and bone mineral density), and
lead to significantly better cardiovascular health and
reduced risk to develop cardiovascular disease [8,17-19].
Previous studies have shown that disease activity signif-
icantly influences direct and indirect RA costs [1]. We
found that disease activity and disability may also impact
upon future admission rates. In fact, we have previously
demonstrated that effective treatment enables patients to
engage with more active lifestyles and better diet [20].
The combination of increased physical activity and effec-
tive medication, therefore, may not only inhibit disease
progression thereby improving quality of life, but it may
also reduce costs by reducing the need for surgery, and
admission to acute and extended care hospitalisation, as
well as social service utilization.
The observed physical activity levels herein are signifi-
cantly lower compared to patients with other chronic dis-
eases, including obesity [21], cancer [22] and osteoarthritis
[23]. More importantly, only a fifth (19%) of the total
wide-range (in terms of age and disease duration) RA
population studied, achieved the recommended levels of
physical activity, a significantly reduced number compared
to the normal population (approximately 35%) [24]. More
importantly, this 19% corresponds mainly to the younger
RA patients. Although it is well-established that aerobic
capacity is significantly compromised in the RA popula-
tion [8], our data also demonstrate that RA patients do
not achieve the physical activity levels required to mini-
mise their risk for developing cardiovascular disease, inhi-
bit age-related muscle loss, improve quality of life and
well-being. Improvement in these parameters is crucial as
the prevalence of cardiovascular disease and cachexia is
higher in RA than in the normal population [10], partly
due to the presence of traditional risk factors [25-28] but
also due to the metabolic and vascular effects of persistent
high-grade inflammation [29,30]. Moreover, physical abil-
ity may be worse due to disease-related processes,
although it may be partly improved by effective treatment
strategies [20]. Participation in structured exercise pro-
grammes is necessary to reversing these phenomena, but
this requires patients to be in a controlled environment.
Involvement in increased physical activity such as leisure
walking, however, is different and requires a different level
of determination and commitment given the lack of
immediate advice that is available in structured exercise
programmes by the instructors. Thus, improving determi-
nation to keep active should be a future focus of interven-
tion strategies in order to improve health and quality of
life in this population.
One of the important limitations of the present study is
the adopted cross-sectional design which is not sufficient
to prove a cause-and-effect relationship between the
parameters studied. As such, it cannot be ensured that
physical activity may have a profound effect on RA,
which in turn will result in reduced admission rates or if,
in contrast, patients who exercise more have lower dis-
ease activity and severity and, hence, they are not
admitted to the hospital frequently. Ensuring quality pri-
mary care has been recognised as a crucial component in
keeping patients with chronic disease out of hospital [31].
It has also been suggested that patients from disadvan-
taged areas have a higher and prolonged rate of admis-
sion [31]. We were not able to standardise for these
factors in the present study; all patients came from a rela-
tively distinct geographical area of the UK, which, how-
ever, contains a diverse socioeconomic strata and
variable access and quality of primary care services. We
also did not assess directly either the effects of hospitali-
sation to quality of life, or the costs incurred as a result
of it. On the other hand, the originality of the question,
use of validated measures in a consistent fashion, as well
as possible mediation or moderation effects, represent
important strengths of the study. Clearly, several of the
associations found here need to be confirmed in future
prospective studies, designed specifically for the purpose.
Conclusions
This study suggests that disease activity and physical activ-
ity are important predictors of the number of hospital
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admissions as well as length of hospitalisation in RA
patients. The combination of lifestyle approaches, in parti-
cular increased physical activity, along with effective phar-
macological management, is likely to provide superior
personal health and health economic outcomes in this
population. However, these remain to be investigated in
appropriately designed studies.
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